13 min

Cardiac Amyloidosis and the V142I Transthyretin Variant JAMA Author Interviews

    • Medicine

What is the natural history and cardiovascular burden of the V142I transthyretin variant among US Black individuals who carry this variant? Senthil Selvaraj, MD, MS, MA, from Duke University, and Scott D. Solomon, MD, from Brigham and Women’s Hospital, discuss this and more with JAMA Executive Editor Gregory Curfman, MD.

Related Content:
Cardiovascular Burden of the V142I Transthyretin Variant Addressing Health Disparities—The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger Heart Failure in African American Individuals, Version 2.0 Cardiac Amyloidosis Due to Transthyretin Protein

What is the natural history and cardiovascular burden of the V142I transthyretin variant among US Black individuals who carry this variant? Senthil Selvaraj, MD, MS, MA, from Duke University, and Scott D. Solomon, MD, from Brigham and Women’s Hospital, discuss this and more with JAMA Executive Editor Gregory Curfman, MD.

Related Content:
Cardiovascular Burden of the V142I Transthyretin Variant Addressing Health Disparities—The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger Heart Failure in African American Individuals, Version 2.0 Cardiac Amyloidosis Due to Transthyretin Protein

13 min

More by JAMA Network

JAMAevidence JAMA Guide to Statistics and Methods
JAMA Network
Coronavirus (COVID-19) Q&A
JAMA Network
JAMA Network Open Conversations
JAMA Network
JAMAevidence Users' Guides to the Medical Literature
JAMA Network
JAMAevidence The Rational Clinical Examination
JAMA Network
JAMAevidence Care at the Close of Life
JAMA Network